Biomerica (BMRA) Operating Expenses (2010 - 2026)

Biomerica (BMRA) has 17 years of Operating Expenses data on file, last reported at $1.3 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses rose 2.03% year-over-year to $1.3 million; the trailing twelve-month figure through Feb 2026 stood at $5.5 million (down 5.53% YoY), and the FY2025 full-year result was $5.6 million, down 19.25% from the prior year.
• Operating Expenses slipped to $1.3 million in Q1 2026, from $1.4 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $2.4 million in Q2 2022 to a low of $1.2 million in Q1 2025.
• A 5-year average of $1.7 million and a median of $1.7 million in 2024 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses jumped 38.83% in 2022 and tumbled 33.6% in 2025, its largest moves.
• Tracing BMRA's Operating Expenses over 5 years: stood at $2.0 million in 2022, then dropped by 4.21% to $1.9 million in 2023, then declined by 26.02% to $1.4 million in 2024, then fell by 0.42% to $1.4 million in 2025, then fell by 11.94% to $1.3 million in 2026.
• Business Quant data shows BMRA's Operating Expenses at $1.3 million in Q1 2026, $1.4 million in Q4 2025, and $1.5 million in Q3 2025.